60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) price on current trading day, fall -12.89% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.50.
A look at the stock’s price movement, the close in the last trading session was $2.87, moving within a range at $2.35 and $2.9299. Turning to its 52-week performance, $35.99 and $1.41 were the 52-week high and 52-week low respectively. Overall, SXTP moved 48.81% over the past month.
60 Degrees Pharmaceuticals Inc’s market cap currently stands at around $3.68 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-26.
Analysts have a consensus estimate of 301k for the company’s revenue for the quarter, with a low and high estimate of 300k and 302k respectively. The average forecast suggests up to a 158.46% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 1.61M, representing a 165.24% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that SXTP is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend SXTP as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
SXTP’s current price about 28.00% and 9.46% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 58.94, while 7-day volatility ratio is 29.94% and 15.00% in the 30-day chart. Further, 60 Degrees Pharmaceuticals Inc (SXTP) has a beta value of 0.44, and an average true range (ATR) of 0.41.
If we refocus on 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP), historical trading data shows that trading volumes averaged 8.67 over the past 10 days and 1.81 million over the past 3 months. The company’s latest data on shares outstanding shows there are 1.47 million shares.
The 6.27% of 60 Degrees Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 2.08% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 51389.0 on 2025-03-14, giving us a short ratio of 0.66. The data shows that as of 2025-03-14 short interest in 60 Degrees Pharmaceuticals Inc (SXTP) stood at 354.0 of shares outstanding, with shares short rising to 23788.0 registered in 2025-02-14. Current price change has pushed the stock -61.24% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SXTP stock continues to rise going into the next quarter.
